ATLANTA, GA-- (Marketwire) - Curing Kids' Cancer has awarded the annual Killian Owen Research Grant to the Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta.
$80,000 was donated to the Aflac Cancer Center's Clinical Research office in memory of Killian Owen, who lost his battle with Acute Lymphoblastic Leukemia in 2003 at the age of nine after a four year battle with the disease. Killian is the inspiration for the charity Curing Kids' Cancer.
"It is virtually impossible to explain how valuable Curing Kids' Cancer is to the children of Atlanta and the surrounding southeastern region," states Dr. William G. Woods, Director of the Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta. "Philanthropic entities like Curing Kids' Cancer make it possible for our staff of physicians and nurses to fight pediatric cancer and get kids back to being kids."
Ad Statistics
Times Displayed: 125799
Times Visited: 7246 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
The donation was the third made to the hospital in 2008. Curing Kids' Cancer donated a total of $200,000 to the Aflac Cancer Center of Children's last year.
"The Aflac Cancer Center of Children's pediatric cancer research programs have expanded rapidly in recent years, and the hospital is making great strides in moving treatments from the lab to the bedside," said Grainne Owen, founder of Curing Kids' Cancer. "We hope our funding will help create more effective, less toxic treatments which will eventually replace traditional chemotherapy and turn childhood cancer from a killer disease into a curable one."
A $10,000 grant was awarded to a Dana-Farber Cancer Institute study which identifies and validates new Acute Myeloid Leukemia "targets," or certain molecules within the cancer that can be attacked with drugs. The studies are being led by Dr. Kimberly Stegmaier and Dr. Scott Armstrong. The grant was made possible by friends and family of Ashley Anderson, a nine-year-old girl from Alpharetta, Ga. who lost her battle with AML in 2006.
A grant was also made to Baylor College of Medicine/Texas Children's Cancer Center to support Dr. Jason Shohet's research towards developing novel treatments for neuroblastoma. Neuroblastoma is a disease in which malignant cancer cells form in nerve tissue of the adrenal gland, neck, chest, or spinal cord. Neuroblastoma most often begins during early childhood, usually in children younger than 5 years old. The average five-year survival rate for children with neuroblastoma is 30 percent.
This is the second grant Curing Kids' Cancer has awarded to Dr. Shohet's research team.
